gadofosveset trisodium has been researched along with minocycline in 1 studies
| Studies (gadofosveset trisodium) | Trials (gadofosveset trisodium) | Recent Studies (post-2010) (gadofosveset trisodium) | Studies (minocycline) | Trials (minocycline) | Recent Studies (post-2010) (minocycline) |
|---|---|---|---|---|---|
| 265 | 32 | 145 | 6,579 | 502 | 2,921 |
| Protein | Taxonomy | gadofosveset trisodium (IC50) | minocycline (IC50) |
|---|---|---|---|
| Multidrug transporter MdfA | Escherichia coli K-12 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andia, ME; Botnar, RM; Ferro, A; Passacquale, G; Phinikaridou, A | 1 |
1 other study(ies) available for gadofosveset trisodium and minocycline
| Article | Year |
|---|---|
Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent.
Topics: Albumins; Animals; Anti-Bacterial Agents; Antioxidants; Atherosclerosis; Azoles; Contrast Media; Endothelium, Vascular; Gadolinium; Isoindoles; Magnetic Resonance Imaging; Male; Mice; Minocycline; Organometallic Compounds; Organoselenium Compounds; Permeability | 2013 |